Publications
- The relapsed AML 2001/01, 02 study for children with relapsed acute myeloid leukaemia or initially resistant disease has improved outcome2011 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Interfant 99 - treatment reflecting unique biology of the infant acute lymphoblastic leukemia. The results in the Czech Republic2009 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Third consecutive national study ALL-BFM 95 improved the outcome of acute lymphoblastic leukemia in children in the Czech Republic2008 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Second national study AML-BFM 98 improved remission rate and overall survival in children with acute myeloid leukemia in the Czech Republic2008 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- The incidence and treatment of relapse of childhood acute lymphoblastic leukemia in the Czech Republic between 1990-20002003 | Second Faculty of Medicine
- The role of TEL and AML1 genes in the pathogenesis of hematologic malignancies2001 | Second Faculty of Medicine
- Monitoring minimal residual disease in pediatric patients with acute lymphoblastic leukemia2000 | Second Faculty of Medicine
- Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia1999 | Second Faculty of Medicine
- Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study2024 | Second Faculty of Medicine
- Chimeric JAK2 Kinases Trigger Non-uniform Changes of Cellular Metabolism in BCR-ABL1-like Childhood ALL2023 | Second Faculty of Medicine, Central Library of Charles University
Loading network view...
